(5alpha,17beta)-3-Oxoandrostan-17-yl heptanoate(CAS: 33776-88-4)

Regulatory guidelines for (5alpha,17beta)-3-Oxoandrostan-17-yl heptanoate (CAS: 33776-88-4) include GHS classification, REACH regulations, and FDA/EPA requirements. This compound falls under the classification of a steroid derivative and requires proper handling, storage, and disposal to comply with these regulations.

Alternatives to (5alpha,17beta)-3-Oxoandrostan-17-yl heptanoate (CAS: 33776-88-4) in synthesis include similar steroid derivatives and analogs. Common alternative reagents such as androst-5-en-3-one and other androsteroid intermediates can be used as substitutes, depending on the specific needs of the synthesis.

The market and research trends for (5alpha,17beta)-3-Oxoandrostan-17-yl heptanoate (CAS: 33776-88-4) are focused on its use in pharmaceuticals and research applications. This compound is of interest due to its biological activity and potential therapeutic uses, driving both industry demand and emerging research fields.

Waste containing (5alpha,17beta)-3-Oxoandrostan-17-yl heptanoate (CAS: 33776-88-4) should be collected in appropriate containers and disposed of through professional waste disposal methods. Incineration or other controlled destruction processes should be used, while ensuring compliance with local environmental protection regulations and safety guidelines.